Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

Also known as: Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB05220	Alisertib	1	Completed	1
DB02379	Beta-D-Glucose	1	Withdrawn	1
DB00262	Carmustine	1	Withdrawn	1
DB00531	Cyclophosphamide	1	Terminated	2
DB00987	Cytarabine	1	Withdrawn	1
DB11714	Durvalumab	1	Terminated	1
DB00773	Etoposide	1	Withdrawn	1
DB01073	Fludarabine	1	Terminated	2
DB17232	JCAR014	1	Terminated	1
DB16222	Loncastuximab tesirine	1	Withdrawn	1
DB00888	Mechlorethamine	1	Withdrawn	1
DB06176	Romidepsin	1	Completed	1
DB17109	Tegavivint	1	Recruiting	1
DB02379	Beta-D-Glucose	2	Recruiting	2
DB00188	Bortezomib	2	Recruiting	1
DB00188	Bortezomib	2	Withdrawn	1
DB16741	Bortezomib D-mannitol	2	Recruiting	1
DB16741	Bortezomib D-mannitol	2	Withdrawn	1
DB00958	Carboplatin	2	Recruiting	1
DB00631	Clofarabine	2	Recruiting	1
DB00531	Cyclophosphamide	2	Recruiting	2
DB01234	Dexamethasone	2	Recruiting	1
DB00773	Etoposide	2	Recruiting	2
DB00099	Filgrastim	2	Recruiting	1
DB01181	Ifosfamide	2	Recruiting	1
DB00480	Lenalidomide	2	Recruiting	1
DB18441	Maplirpacept	2	Recruiting	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB06650	Ofatumumab	2	Recruiting	1
DB17116	Ontorpacept	2	Recruiting	1
DB00019	Pegfilgrastim	2	Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	1
DB00073	Rituximab	2	Recruiting	1
DB00073	Rituximab	2	Withdrawn	1
DB15044	Tafasitamab	2	Recruiting	1
DB11930	Varlilumab	2	Active Not Recruiting	1
DB11581	Venetoclax	2	Withdrawn	1
DB00541	Vincristine	2	Recruiting	1
DB15035	Zanubrutinib	2	Recruiting	1